{
    "title": "Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.",
    "doc_id": "30005774",
    "writer": "Menta A",
    "year": "2018",
    "summary": "Inflammatory breast cancer (IBC) is a rare form of breast cancer that accounts for only 2% to 4% of all breast cancer cases. Despite its low incidence, IBC contributes to 7% to 10% of breast cancer caused mortality. Despite â€¦",
    "abstract": "Inflammatory breast cancer (IBC) is a rare form of breast cancer that accounts for only 2% to 4% of all breast cancer cases. Despite its low incidence, IBC contributes to 7% to 10% of breast cancer caused mortality. Despite ongoing international efforts to formulate better diagnosis, treatment, and research, the survival of patients with IBC has not been significantly improved, and there are no therapeutic agents that specifically target IBC to date. The authors present a comprehensive overview that aims to assess the present and new management strategies of IBC.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/30005774/",
    "clean_text": "inflammatory breast cancer what to know about this unique aggressive breast cancer inflammatory breast cancer ibc is a rare form of breast cancer that accounts for only to of all breast cancer cases despite its low incidence ibc contributes to to of breast cancer caused mortality despite inflammatory breast cancer ibc is a rare form of breast cancer that accounts for only to of all breast cancer cases despite its low incidence ibc contributes to to of breast cancer caused mortality despite ongoing international efforts to formulate better diagnosis treatment and research the survival of patients with ibc has not been significantly improved and there are no therapeutic agents that specifically target ibc to date the authors present a comprehensive overview that aims to assess the present and new management strategies of ibc"
}